Welcome to our dedicated page for Cannae Holdings SEC filings (Ticker: CNNE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cannae Holdings juggles O’Charley’s kitchens, Dun & Bradstreet data vaults, and tech-enabled healthcare ventures—all inside one portfolio. That diversity translates into sprawling regulatory paperwork. Investors searching for Cannae Holdings insider trading Form 4 transactions or the latest Cannae Holdings quarterly earnings report 10-Q filing often spend hours scrolling through EDGAR. The good news: you don’t have to.
Stock Titan’s AI-powered summaries turn dense documents into clear takeaways. Need the Cannae Holdings annual report 10-K simplified or Cannae Holdings 8-K material events explained? We deliver concise highlights with numbers tied directly to the Restaurant Group, Dun & Bradstreet, and Alight stakes. Real-time alerts surface Cannae Holdings executive stock transactions Form 4 the instant they post, while our dashboards present Cannae Holdings proxy statement executive compensation details without jargon—Cannae Holdings SEC filings explained simply.
What you can do here:
- Track Cannae Holdings Form 4 insider transactions real-time to spot buying and selling trends
- Run Cannae Holdings earnings report filing analysis that compares segment performance quarter over quarter
- Accelerate understanding Cannae Holdings SEC documents with AI by using red-flag keywords and side-by-side comparisons
Every 10-Q, 10-K, 8-K, or registration statement lands on this page the moment it’s filed, complete with expert context and machine-readable highlights. Stop digging; start deciding.
Ryan R. Caswell, CEO of Cannae Holdings (CNNE), reported transactions dated 08/13/2025. The filing shows an acquisition of 100,000 restricted stock units (RSUs), increasing RSU holdings to 350,000 after the grant. Each RSU represents the right to one share, includes pass-through voting and accrued dividend rights, and vests in three equal annual installments beginning August 13, 2026. The filing also reports a disposition of 266,846 shares of common stock. The form was filed by one reporting person and signed by an attorney-in-fact.
Cannae Holdings reported a material loss driven by investment-related charges and operating weakness. The company recorded a net loss of $240.5 million for the quarter and $355.5 million for the six months, equal to basic net loss per share of $(3.93) for the quarter and $(5.72) for six months. Total operating revenues were $110.2 million in the quarter with an operating loss of $60.9 million, while equity in losses of unconsolidated affiliates was $(95.7) million for the quarter.
Significant items include a $59.1 million other-than-temporary impairment of Alight and a $68.1 million impairment related to Dun & Bradstreet after reclassifying D&B as a discontinued operation and held for sale ($528.0 million). The company sold 10.0 million D&B shares for $89.5 million and retained ~59.0 million shares (~13.2%).
The balance sheet shows total assets declined to $1,785.8 million from $2,228.9 million, cash fell to $66.7 million from $131.5 million, and investments in unconsolidated affiliates declined to $629.9 million. Management changes and related payments were recorded, including a $17.2 million lump-sum payment to William Foley and accelerated equity vesting.
Carronade Capital has filed a preliminary proxy solicitation against Cannae Holdings (CNNE) and nominated four independent directors to seek board seats. The activist, which beneficially owns approximately 3.19 million shares, is pressing the board for answers on governance and capital return after Cannae sold its stake in Dun & Bradstreet for $632 million. Carronade notes Cannae committed to return at least $300 million of those proceeds via buybacks and has repurchased about $100 million so far, asking whether the remaining $200 million will go to non-insider shareholders or be used to repurchase shares tied to Executive Chairman Bill Foley at a 20% premium. The activist also highlights weak historical shareholder returns and questions Foley’s new director services agreement and recent board changes.
Cannae Holdings, Inc. (CNNE) – Form 4 filing dated 07/01/2025
Director Erika Meinhardt reported a single insider transaction on 06/30/2025. Under the company’s Director Retainer Election Program, she acquired 810 shares of CNNE common stock (Transaction Code A) at an indicated value of $20.85 per share. Following the grant, Meinhardt now holds 135,202 shares directly.
No derivative securities were involved and there were no dispositions. The filing was made individually (not a joint filing) and was signed by attorney-in-fact Carol Nairn on 07/01/2025.
- Nature of acquisition: non-open-market, compensation-related.
- Ownership impact: increases direct holdings by +0.6% (810 ÷ 134,392 prior shares).
- Regulatory note: the transaction complies with Section 16(a) reporting obligations.
Cannae Holdings, Inc. (CNNE) – Form 4 insider filing
Director Hugh R. Harris disclosed the receipt of 780 shares of CNNE common stock on 30 June 2025 at a price of $20.85 per share (approx. $16.3 k total). The shares were issued through the company’s Director Retainer Election Program, indicating the director elected to receive equity compensation in lieu of cash fees. After the grant, Harris directly owns 58,147 shares of CNNE. No derivative transactions were reported.
Carronade Capital, owning approximately 3.2 million shares of Cannae Holdings, has filed a DFAN14A regarding a proxy contest. The investment firm is pushing for significant board changes and calling for the immediate announcement of the 2025 Annual Meeting date, which has been delayed beyond the usual schedule.
Key concerns raised by Carronade include:
- Criticism of Cannae's delay in scheduling the 2025 Annual Meeting, viewing it as an attempt to manipulate corporate machinery
- Questions about the company's reincorporation from Delaware to Nevada
- Demands for clarity on capital return plans following the Dun & Bradstreet sale
- Request for shareholder-favorable terms in any potential tender offer
Carronade has nominated four independent directors: Mona Aboelnaga, Benjamin Duster, Dennis Prieto, and Cherie Schaible. The firm, managing over $2.3 billion in assets, is led by Dan Gropper and currently holds approximately 3.19 million shares through various entities.